CameraVax Inc. 扩大研究范围,以针对罕见肝癌,建立新的免疫加速平台。 CancerVax Inc. expands research to target rare liver cancers with a new immune-boosting platform.

CameraVax Inc. 正在扩大其临床前期计划, 以包括罕见的肝癌形式, HCC 和 ICC, 使用创新平台, CancerVax Inc. is expanding its preclinical program to include rare forms of liver cancers, HCC, and ICC, using its innovative platform that targets cancer cells without harming healthy ones. 该公司的脂质纳米粒子 检测癌症细胞 并标记它们 免疫系统摧毁。 The company's lipid nanoparticles detect cancer cells and mark them for the immune system to destroy. 这一扩展补充了它们目前关于胰腺癌的工作,目的是通过普及治疗办法解决大量未满足的需要,提供现成的癌症治疗。 This expansion adds to their existing work on pancreatic cancer, aiming to address significant unmet needs with a universal treatment approach that could provide off-the-shelf cancer therapies.